26922

26922
Food and Drug Administration (FDA). FDA Drug Safety Communication: FDA requires post-market safety trials for Long-Acting Beta-Agonists (LABAs); 2011 [cited 2017-00-19]. http://www.fda.gov/Drugs/DrugSafety/ucm251512.htm.
Einstellungen
26922
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 17.12.2020 | 17:17 Uhr